Exercise after cancer therapy: a new way to gauge prognosis?

NCT ID NCT06666881

Recruiting now Disease control Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether a high-intensity interval training (HIIT) program can help head and neck cancer patients maintain or improve muscle mass after chemoradiotherapy. Researchers will use imaging and blood tests to see if changes in muscle and inflammation markers can predict patient prognosis. The study involves 60 participants, half doing HIIT and half as a control group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High-intensity interval training (HIIT) exercise program
What this could lead to: If successful, this could show that exercise helps maintain muscle mass and may improve outcomes for head and neck cancer patients.
What could go wrong: This is a small, early-stage study. Results may not apply to all patients, and exercise may not be feasible for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER SKELETAL MUSCLE

Contacts and locations

Locations

New Taipei City TuCheng Hospital
RECRUITING

New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.